Arcus Biosciences, Inc.
RCUS
$28.74
$0.020.07%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -91.00M | -128.00M | -106.00M | -135.00M | 0.00 |
| Total Depreciation and Amortization | 3.00M | 2.00M | 3.00M | 2.00M | 2.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.00M | 19.00M | 13.00M | 15.00M | 13.00M |
| Change in Net Operating Assets | -47.00M | -31.00M | -30.00M | 21.00M | -148.00M |
| Cash from Operations | -119.00M | -138.00M | -120.00M | -97.00M | -133.00M |
| Capital Expenditure | -- | -- | -1.00M | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 52.00M | 114.00M | -181.00M | 79.00M | 137.00M |
| Cash from Investing | 52.00M | 114.00M | -182.00M | 79.00M | 137.00M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 49.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 16.00M | 3.00M | 286.00M | 8.00M | 3.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 16.00M | 3.00M | 286.00M | 8.00M | 52.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -51.00M | -21.00M | -16.00M | -10.00M | 56.00M |